e.nilsen

TL2 · Kumasi

Contributes reviews on supplier material. Based in Kumasi.

Joined 25 November 2024 · last posted 5d

77 posts, newest first. Showing up to 150.

Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #105 · Evidence › Journal club · 23 Jul 2026 · 7 likes I have been on both sides of the SUSTAIN 6 argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #75 · Practice › Interactions · 22 Jul 2026 · 3 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
Compounds this community declines to help with, and why — does this still hold? Replied, post #7 · Compounds › Other compounds · 21 Jul 2026 · 2 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Here for the analytics and not much else Replied, post #50 · Lounge › Introductions · 18 Jul 2026 · 5 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right. Second-hand, so…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #17 · Evidence › Study critique · 14 Jul 2026 · 14 likes I would call the community position on Selection likely rather than established, and I would be comfortable defending that hedge.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #111 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 1 like Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #11 · Practice › Dosing & titration · 4 Jul 2026 · 0 likes Where I part company with post #9, and it is a narrow parting. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
Why this subcategory is stricter about sourcing than most Replied, post #49 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 2 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #48 · Practice › Administration · 27 Jun 2026 · 23 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
Journal club: what we got wrong in an earlier session Replied, post #18 · Evidence › Journal club · 21 Jun 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #61 · Outcomes › Progress reports · 17 Jun 2026 · 1 like Coming back to post #60, because the follow-up matters more than the original answer. Self-reported intake is optimistic in a consistent direction, and saying so in…
Journal club: what we got wrong in an earlier session Replied, post #6 · Evidence › Journal club · 15 Jun 2026 · 11 likes Answering the question post #5 raises rather than the one it answers. A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor.…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #23 · Documentation › Doc review · 14 Jun 2026 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
Search filters: what is missing Replied, post #65 · Meta › Site feedback · 4 Jun 2026 · 0 likes Post #63 describes the usual case. This is about the unusual one. Feedback on the search: the status filter is the most useful control on the site and it is the least…
Tracking a shortage from primary sources rather than rumour Replied, post #11 · Access › Shortages · 16 May 2026 · 9 likes Reading rather than answering, but this is the post I would point somebody at.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #41 · Compounds › Tirzepatide · 11 May 2026 · 1 like Answering the question post #39 raises rather than the one it answers. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #36 · Analytics › COA interpretation · 4 May 2026 · 7 likes Reading back through the Reused chromatograms across lots threads from last year, the same three questions come up every time and only one of them has ever been…
A site rotation scheme that is easy enough to actually follow Replied, post #53 · Practice › Administration · 1 May 2026 · 11 likes Everything in post #52 holds. The case it does not cover is the one I have. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising…
Personal import allowances, compared — a second dataset Replied, post #114 · Access › International · 1 May 2026 · 13 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
Prescription requirements and telehealth models — a second dataset Replied, post #16 · Sourcing › Regulatory · 30 Apr 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
The anatomy of a question that gets answered within an hour Replied, post #25 · Start Here › How to Ask · 22 Apr 2026 · 1 like When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #53 · Data & Tools › Datasets · 18 Apr 2026 · 0 likes Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every one of those words appears in the description.
Revisiting: Absolute versus relative contraindications Replied, post #69 · Safety › Contraindications · 18 Apr 2026 · 9 likes The section of the product information covering special warnings is usually longer and more useful than the contraindications list itself.
Foaming during reconstitution and whether it matters — the long version Replied, post #97 · Practice › Reconstitution · 13 Apr 2026 · 0 likes Narrowing post #96, because the general version has more than one answer. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
Sample handling between despatch and injection Replied, post #31 · Analytics › Method validation · 10 Apr 2026 · 13 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Spike-and-recover accuracy for a peptide assay Replied, post #88 · Analytics › Method validation · 10 Apr 2026 · 2 likes Post #86 put the caveat in the right place and I want to underline it. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of…
Follow-up: State-level differences that actually matter Replied, post #14 · Regional › North America · 4 Apr 2026 · 10 likes Post #12 describes the usual case. This is about the unusual one. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
A 10 mg vial reconstituted three different ways, compared Replied, post #11 · Practice › Reconstitution · 27 Mar 2026 · 0 likes Everything in post #10 holds. The case it does not cover is the one I have. Reconstituting the whole vial when you will use a quarter of it is a decision to store the…
Why the timeline is on the right and not the left — what changed since Replied, post #3 · Meta › Site feedback · 4 Mar 2026 · 10 likes The opening post and I disagree about the size of the effect, not about the direction. Community norms: if you think a norm has drifted or is not being followed…
Preprint servers and what screening they do Replied, post #72 · Evidence › Preprints · 28 Feb 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #51 · Clinical › Bloodwork · 16 Feb 2026 · 0 likes A methods point on reference intervals rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #18 · Pharmacology › Receptor biology · 19 Dec 2025 · 20 likes This is the sort of exchange that makes the archive worth searching.
Batch date after test date, and other internal inconsistencies Replied, post #27 · Analytics › COA interpretation · 15 Dec 2025 · 4 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
Documentation that materially improves an appeal's chances Replied, post #87 · Access › Insurance & coverage · 2 Dec 2025 · 0 likes I had written a reply contradicting post #85 and deleted it. Here is what survived. A peer-to-peer review is available in many systems and is frequently more productive…
MHRA statements, read directly Replied, post #34 · Regional › UK & Ireland · 19 Nov 2025 · 10 likes Answering the question post #30 raises rather than the one it answers. What I can speak to on MHRA statements is narrow, so I will keep it narrow rather than…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #54 · Compounds › Tirzepatide · 13 Nov 2025 · 1 like Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Publishing an inconvenient result: a case study — the long version Replied, post #28 · Sourcing › Independent verification · 5 Nov 2025 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Filing this under things that are true…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #3 · Compounds › Semaglutide · 12 Oct 2025 · 2 likes Narrowing the opening post, because the general version has more than one answer. Approved indications differ by jurisdiction and change. As of mid-2026 the…
New subcategory: rationale and scope Replied, post #4 · Meta › Announcements · 11 Oct 2025 · 1 like Last note on this: announcements here get more replies than most topics and almost all of them are questions about scope. That is a hint about what an announcement…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #56 · Practice › Side effects · 12 Sep 2025 · 28 likes Reading back through, this was answered upthread and I missed it. My fault.
High-resolution MS on aggregates and what it can see Replied, post #60 · Analytics › Mass spectrometry · 5 Sep 2025 · 9 likes The arithmetic in post #57 is right; the assumption feeding it is the part to check. Where I would push back on the high-resolution consensus is the confidence, not the…
A comparison of home results against a laboratory result on the same vial Replied, post #30 · Analytics › Home & field testing · 28 Aug 2025 · 4 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. It cost nothing to check…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #13 · Data & Tools › Datasets · 23 Aug 2025 · 28 likes Everything in post #11 holds. The case it does not cover is the one I have. Where a value is derived rather than measured, mark it. Derived columns get treated as…
Revisiting: German, French and Dutch differences, compared Replied, post #62 · Regional › European Union · 22 Aug 2025 · 29 likes Where I part company with post #60, and it is a narrow parting. The public assessment report published at authorisation is one of the best free technical documents…
Managing an unplanned gap in supply — what changed since Replied, post #39 · Access › Shortages · 16 Aug 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
A request that was declined, and the reasoning — a second dataset Replied, post #84 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Taking post #83 at face value and following it one step further. Format suggestions: if you think a maintained page could be clearer in its presentation (different…
Are there stupid questions here? A staff answer, at length Replied, post #69 · Start Here › Welcome · 13 Aug 2025 · 10 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Thyroid function tests during substantial weight change Replied, post #24 · Clinical › Bloodwork · 7 Aug 2025 · 4 likes Liver enzyme changes during rapid weight loss are commonly reported and have several possible explanations, which is exactly why they need clinical interpretation…
Canadian access and provincial variation — one year on Replied, post #34 · Regional › North America · 26 Jul 2025 · 0 likes I had written a reply contradicting post #30 and deleted it. Here is what survived. The most useful contribution is the current published criterion with a link and an…
Sequence verification for an obscure compound: how it is done Replied, post #105 · Compounds › Other compounds · 26 Jul 2025 · 16 likes Adding the measurement that post #104 says would settle it. For anyone finding this later: the short answer on sequence verification is that it depends on one thing,…
Which panel is worth repeating and which is worth ignoring Replied, post #58 · Clinical › Bloodwork · 11 Jul 2025 · 9 likes Post #55 put the caveat in the right place and I want to underline it. Distinguishing three things in the panel discussion that keep getting used interchangeably: the…
Sodium, potassium and magnesium when intake drops Replied, post #45 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2025 · 9 likes Picking up post #42: that is the part I would want checked first. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and…
Discussing something you have already been doing — the long version Replied, post #4 · Clinical › Prescriber conversations · 5 Jul 2025 · 1 like If you have been doing something the prescriber does not know about, saying so is more useful than not. Clinicians here consistently say they would rather know. If this…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #63 · Pharmacology › Pharmacokinetics · 24 Jun 2025 · 11 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #42 · Evidence › Trials · 31 May 2025 · 16 likes The arithmetic on Comparators chosen for regulatory reasons is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #49 · Practice › Reconstitution · 8 May 2025 · 17 likes Worth separating 10 mg vial reconstituted three as a question about the compound from 10 mg vial reconstituted three as a question about the documentation. They get…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #22 · Sourcing › Independent verification · 28 Apr 2025 · 13 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Coverage for the indication versus for the drug Replied, post #41 · Access › Insurance & coverage · 24 Apr 2025 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #134 · Sourcing › Regulatory · 21 Apr 2025 · 7 likes Worth separating Research-use-only labelling as a question about the compound from Research-use-only labelling as a question about the documentation. They get answered…
Shakes versus food: a pragmatic assessment — the long version Replied, post #2 · Nutrition & Training › Protein & intake · 15 Apr 2025 · 3 likes The most useful thing anyone has posted about Shakes versus food in this category was a table of what had been measured and by whom. That is what I would want again.
When "no data" is the complete and final answer Replied, post #148 · Compounds › Other compounds · 14 Apr 2025 · 17 likes Fair, and the limits you put on it are the part I will remember.
Retatrutide dose escalation in the published trials Replied, post #56 · Compounds › Retatrutide · 27 Mar 2025 · 0 likes If someone has run retatrutide dose escalation properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Scheduled maintenance and what will be unavailable Replied, post #79 · Meta › Announcements · 20 Mar 2025 · 25 likes Trying to state the scheduled maintenance position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
About the Repair & healing peptides category Replied, post #3 · Compounds › Repair & healing peptides · 12 Mar 2025 · 1 like As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Consistent declarations and why they matter more than clever ones Replied, post #139 · Sourcing › Logistics · 7 Mar 2025 · 7 likes Consistent declarations is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #40 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes An update on my earlier pharmaceutical compounding rules post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
What we do not know about retatrutide, listed explicitly Replied, post #100 · Compounds › Retatrutide · 17 Feb 2025 · 9 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Reading an MS report that only gives you a single number Replied, post #10 · Analytics › Mass spectrometry · 13 Feb 2025 · 23 likes Answering the question post #8 raises rather than the one it answers. Resolution: "high resolution" commonly means Filing this under things that are true until someone…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #32 · Practice › Reconstitution · 13 Feb 2025 · 0 likes A definition problem is doing most of the work in this reconstituting a multi-strength kit discussion. Once the term is pinned down I suspect the disagreement mostly…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #8 · Analytics › COA interpretation · 15 Jan 2025 · 24 likes Sensible. I would want the same detail before I acted on it either.
EMA product information as a primary source — does this still hold? Replied, post #133 · Regional › European Union · 18 Nov 2024 · 3 likes France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #16 · Compounds › Semaglutide · 8 Nov 2024 · 5 likes Picking up post #13: that is the part I would want checked first. Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #58 · Practice › Administration · 26 Sep 2024 · 5 likes Two sentences on site rotation scheme and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
A rising related-substance total over six months: degradation or method drift? Replied, post #7 · Analytics › Impurities & related substances · 25 Aug 2024 · 12 likes The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two…
Progressive overload when the scale is falling — one year on Started this topic · Nutrition & Training › Resistance training · 22 Aug 2024 · 31 likes Progressive overload when the scale is falling — one year on Writing it up because I had to work it out twice and would rather nobody else did. The question about…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 31 Jul 2024 · 26 likes Everything in post #17 holds. The case it does not cover is the one I have. Fluid intake and electrolyte intake are separate questions and drinking more water alone can…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #34 · Practice › Dosing & titration · 7 Jul 2024 · 7 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. Adding the boring version of Splitting a weekly dose, because the…